AZD-1222/elasomeran/tozinameranRetinal vein occlusion

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2012卷 / 1期

关键词：

D O I：

10.1007/s40278-024-60729-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：66 / 66

相关论文

共 50 条

[1] AZD-1222/Elasomeran/TozinameranVarious toxicities
Reactions Weekly, 2024, 1996 (1) : 49 - 49
[2] AZD-1222/elasomeran/tozinameranVarious toxicities
Reactions Weekly, 2024, 2008 (1) : 66 - 66
[3] AZD-1222/elasomeran/tozinameranVarious toxicities
Reactions Weekly, 2024, 2005 (1) : 148 - 148
[4] AZD-1222/elasomeran/tozinameranVarious toxicities
Reactions Weekly, 2024, 2013 (1) : 76 - 77
[5] AZD-1222/elasomeran/tozinameranVarious toxicities
Reactions Weekly, 2024, 1989 (1) : 49 - 49
[6] AZD-1222/Elasomeran/TozinameranVulval ulcers
Reactions Weekly, 2024, 1995 (1) : 38 - 38
[7] AZD-1222/elasomeran/tozinameranVarious toxicities
Reactions Weekly, 2024, 1992 (1) : 44 - 44
[8] AZD-1222/Elasomeran/TozinameranBell's palsy
Reactions Weekly, 2023, 1987 (1) : 52 - 52
[9] Ad26.COV2-s/AZD-1222/tozinameranRetinal vein occlusion and retinal artery occlusion: 14 case reports
Reactions Weekly, 2022, 1935 (1) : 19 - 19
[10] AZD-1222/elasomeran/tozinameranAnaphylaxis: 5 case reports
Reactions Weekly, 2023, 1985 (1) : 107 - 107

← 1 2 3 4 5 →